PT  - JOURNAL ARTICLE
AU  - Chung, Cheng-Yu
AU  - Wang, Wen-Hwa
AU  - Yin, Chun-Hao
AU  - Chen, Jin-Shuen
AU  - Chen, Yao-Shen
AU  - Yen, Cheng-Chang
AU  - Lin, Ching-Huang
TI  - A Novel Easy-To-Access Model That Predicts Stroke-Associated Pneumonia
AID  - 10.1101/2023.07.13.23292637
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.07.13.23292637
4099  - http://medrxiv.org/content/early/2023/07/16/2023.07.13.23292637.short
4100  - http://medrxiv.org/content/early/2023/07/16/2023.07.13.23292637.full
AB  - BACKGROUND Stroke-associated pneumonia (SAP) is a common poststroke complication but the influence of early neurological deterioration (END) on SAP risk remains unclear. We aimed to develop an easy-to-access model to predict SAP and evaluate the SAP–END relationship using the Glasgow Coma Scale (GCS).METHODS This retrospective study enrolled consecutive patients aged ≥20 years with first-ever acute ischemic stroke at Kaohsiung Veterans General Hospital between January 1, 2010, and November 30, 2020. SAP was defined according to modified Centers for Disease Control and Prevention criteria. Patients’ baseline characteristics, laboratory data within 24 h, neurological findings, and serial GCS scores within 48 h were collected. Regression analysis was used to identify independent risk factors for SAP.RESULTS Among 1009 enrolled patients, SAP occurred in 85 (8.4%) patients. Using multivariate analysis, END after admission (adjusted odds ratio [aOR] 2.94, 95% confidence interval [CI] 1.74–4.95, P<0.001) remained significant after adjusting for confounders. Initial GCS score <10 (aOR 2.30, 95% CI 1.30–4.06, P=0.004), National Institutes of Health Stroke Scale (NIHSS) score 5–15 (aOR 2.02, 95% CI 1.09–3.73, P=0.026) or ≥16 (aOR 3.45, 95% CI 1.72–6.89, P<0.001), cardioembolism (aOR 4.76, 95% CI 1.90–11.91, P=0.014), undetermined etiology (aOR 3.41, 95% CI 1.29–9.03, P=0.001), and neutrophil-to- lymphocyte ratio (NLR) >2.5 (aOR 2.10, 95% CI 1.28–3.46, P=0.004) were also significant. The area under the curve (AUC) of combined GCS score, END, NIHSS score, cardioembolism, stroke with undetermined type, and NLR was 0.83 (95% CI 0.78–0.87, P<0.001), which was superior to that of PANTHERIS scores (0.62, 95% CI 0.55–0.68, P<0.001).CONCLUSIONS This study developed a simple predictive model for SAP using easily accessible and generally available parameters. GCS-based END was an independent risk factor for SAP. Early identification of SAP risk factors and reversible END causes may lower SAP incidence.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by grants from KVGH (KSVGH111-075, KSVGH111-088) and the Ministry of Science and Technology (MOST110-2314-B075-B-013)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethics committee of KVGH (KSVGH22-CT4-12). The requirement for patient consent was waived because of the retrospective observational study design and because the study involved no increase in health risks to any patient.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes